•  
  •  
  •  
  •  

2025-12-19 19:56:27

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Advait Energy Transitions Ltd receives order worth Rs. 99.99 crores
  • Ather Energy to Venture into Auto Insurance distribution
  • Shriram Pistons & Rings Ltd enters into asset purchase agreement with Sunbeam
  • Gujarat Ambuja Exports Ltd commissions 30,000 TPA Sodium Gluconate Plant at Hubli, Karnataka
  • DMR Engineering Ltd receives order worth Rs. 74.50 lakhs

Keywords Selected:  AstraZenecaPharmaIndia

Stock Report

  • AstraZeneca Pharma India Ltd receives permission from CDSCO for Datopotamab Deruxtecan powder
  • AstraZeneca Pharma India Ltd and Sun Pharma partner to help patients living with Hyperkalaemia in India
  • AstraZeneca Pharma India Ltd to launch Sodium Zirconium Cyclosilicate powder in Nov 2025
  • AstraZeneca Pharma India Ltd receives sale and distribution approval from CDSCO for Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder
  • AstraZeneca Pharma India Ltd receives permission from CDSCO for Durvalumab Solution
  • AstraZeneca Pharma India Ltd surrenders marketing authorisation for Olaparib 100mg and 150mg
  • AstraZeneca Pharma India Ltd to discontinue the manufacturing and marketing of Imdur from April 1, 2025
  • AstraZeneca Pharma India Ltd receives permission for Olaparib film-coated tablets
  • AstraZeneca Pharma India Ltd to launch Breztri Aerosphere in January 2025 in India
  • AstraZeneca Pharma India Ltd to launch Tremelimumab
  • AstraZeneca Pharma India Ltd to launch Palivizumab in India
  • AstraZeneca Pharma India Ltd updates on exploring contract manufacturer
  • AstraZeneca Pharma India Limited achieves growth of 29% for financial year ended March 31, 2024
  • AstraZeneca Pharma India Ltd and Mankind Pharma partner to accelerate access to asthma medicine for patients in India
  • AstraZeneca Pharma India Ltd receives permission to import new drug
  • AstraZeneca Pharma India Ltd to launch Enhertu in January 2024
  • AstraZeneca Pharma India Ltd receives permission from CDSCO to import new drug
  • AstraZeneca Pharma India Ltd receives permission to Import pharmaceutical formulations of new drug for sale
  • AstraZeneca Pharma India receives permission to import Palivizumab solution for injection
  • AstraZeneca Pharma India Ltd Q1 FY2024 PAT climbs to Rs. 53.86 crore
  • AstraZeneca Pharma India Ltd receives permission from DCGI for Dapagliflozin Tablets 10 mg
  • AstraZeneca Pharma India Ltd receives permission for sale and distribution of Trastuzumab deruxtecan
  • AstraZeneca Pharma India Ltd Q3 FY2022-23 PAT at Rs. 29.30 crores
  • AstraZeneca Pharma India receives permission for Dapagliflozin tablets

Latest Post

  • Advait Energy Transitions Ltd receives order worth Rs. 99.99 crores
  • Ather Energy to Venture into Auto Insurance distribution
  • Shriram Pistons & Rings Ltd enters into asset purchase agreement with Sunbeam
  • Gujarat Ambuja Exports Ltd commissions 30,000 TPA Sodium Gluconate Plant at Hubli, Karnataka
  • DMR Engineering Ltd receives order worth Rs. 74.50 lakhs


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024